Drug Trial Radar · NCT04684147
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
Last checked: Nov 19, 2026Latest source record: Aug 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Dec 24, 2020
Primary completion
Sep 22, 2022
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Juventas Cell Therapy Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 24, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a Phase II, single-arm, open-label, single-dose clinical trial, and its primary objective is to evaluate the efficacy and safety of CNCT19 Cell Injection in the treatment of CD19 positive Relapsed or Refractory acute lymphoblastic leukemia.
Conditions
- Relapsed or Refractory Acute Lymphoblastic Leukemia
Interventions
single dose of CNCT19Biological
Dose: 0.5 x 10\^8 CNCT19 Cell Injection via intravenous infusion. Drug: Fludarabine Drug: Cyclophosphamide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Remission Rate (ORR), which includes Complete Remission (CR) and Complete Remission with Incomplete Blood Count Recovery (CRi) as determined by Independent Review Committee (IRC).Time frame: At 3 months after infusion
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Beijing Boren Hospital
Beijing, Beijing Municipality, China · Recruiting
Xinqiao Hospital of TMMU
Chongqing, Chongqing Municipality, China · Recruiting
Nanfang Hospital
Guangzhou, Guangdong, China · Recruiting
Yanda hospital, Hebei medical university
Sanhe, Hebei, China · Not yet recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
The affiliated hospital of Xuzhou medical university
Xuzhou, Jiangsu, China · Recruiting
Tongji Hospital of Tongji University
Shanghai, Shanghai Municipality, China · Recruiting
West China Hospital,Sichuan University
Chengdu, Sichuan, China · Recruiting
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China · Recruiting
The First Affiliated Hospital, Zhejiang University school of Medicine
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.